Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 26-50 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients to provide a safe and low-cost way to cure or lowering the consequences of COVID-19
Design:
Phase (...) :
Inclusion:
Healthy individuals exposed directly and constantly with COVID-19 patients.
COVID-19 patients who
Study aim:
Evaluating the IL-6 level in COVID-19 patients hospitalized in Intensive Care Unit (ICU), after consuming Fluvoxamine.
Comparing the IL-6 level in two groups of COVID-19 patients, hospitalized (...) Massih Daneshvari Hospital, which 40 hospitalized patients in ICU ward due to COVID-19 are selected by
Saffron petal and mountain tea herbs on the clinical and paraclinical symptoms of COVID-19 patients (...) /Inclusion and exclusion criteria:
Inclusion criteria in this study included all patients in whom Covid19(...) intervention group includes patients with COVID-19 who receive herbal compounds (including aqueous extract of
care system (application) of covid19 patients on the severity and duration of symptoms of this disease (...) and Spo2 in the blood of covid19 patients.
Design:
Quasi-experimental study, with simple individual (...) blind, with pretest and posttest, on 70 patients with covid19
Settings and conduct:
This research on
Study aim:
Evaluation the effect of Polypodium root preparation on the management of Covid-19 mild (...) control group) by randomizing the random number table
Settings and conduct:
COVID-19 positive rapid test (...) criteria:
Patients with COVID-19 positive rapid test or RT-PCR; aged 18 to 70 years with gastrointestinal
psychological symptoms associated with Covid-19 pandemic in individuals with a history of Covid-19 infection or (...) Kermanshah, questionnaires (GAD-7,Coronavirus Anxiety Scale ,OCS ,COVID-19-PTSD and sleep quality) will be (...) criteria:
People who became infected with the virus themselves or a family member during the Covid-19
pneumonia in patients with moderate to severe COVID-19
Design:
Clinical trial with control group, parallel (...) randomized clinical trial will be performed on patients with COVID-19 admitted to Mazandaran teaching (...) /Inclusion and exclusion criteria:
Inclusion:
Children and adults with moderate to severe COVID-19
Having one
management of COVID-19.
Design:
This is a single arm, with no control group, not blinded and randomized (...) symptoms and signs who are admitted in ICU) complications of COVID-19, will receive septimeb (infusion) for (...) years
Known case of Covid-19 by relative signs, symptoms, Lab., radiology and CT scan Data.
Existence
health belief model in adopting Covid-19 preventive behaviors in teachers in Karaj.
Design:
A clinical (...) with the aim of promoting preventive behaviors from Covid-19 based on the Health Belief Model. The (...) conditions for entering the study.
Prerequisite for inclusion in the study is a history of Covid-19
Study aim:
The effect of bromhexine on the course of clinical signs in patients with COVID-19 will (...) .
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Patients with PCR-positive for COVID-19(...) :
Intervention group: will receive a standard regimen for COVID-19 plus Bromhexine. Control group: will receive a
Study aim:
To determine the efficacy and immunogenicity of COVID-19 inactivated vaccine (Shifa (...) , immunogenicity, any adverse events, and COVID-19 incidence.
Participants/Inclusion and exclusion criteria:
Main (...)COVID-19, history of close contact with COVID-19 patient in the last 14 days, history of allergy to the
with Coronavirus disease (COVID-19)
Design:
Clinical trial, no control group, no randomization, phase (...) patients with a diagnosis of Covid-19 disease admitted to the intensive care unit of Hazrat Rasoul Akram (...) /Inclusion and exclusion criteria:
Coronavirus disease (COVID-19) admitted in the intensive care unit (ICU
extract as adjunctive treatment on pulmonary symptoms and mortality rate in patients with COVID-19
Design:
A randomized phase 2 controlled clinical trial on 190 patients with COVID-19
Settings and conduct (...) with COVID-19. After giving sufficient explanations and obtaining written informed consent from the
behavior of patients with COVID-19
Design:
The clinical trial has a control group with single blind and randomized parallel groups on 40 patients with COVID-19 and random numbers table is used for randomization (...) infectious diseases),during which 40 patients of COVID-19 who needed home quarantine were randomly divided
patients with covid19
Design:
This trial (Phase 3) is performed on 80 patients using a parallel design (...) and exclusion criteria:
Patients with covid19 with 18 to 80 years of age will enter to the study (...) outcome variables:
Improving the symptoms of Covid19; duration of hospital stay; SPO2 to FiO2 ratio
patients with COVID-19
Design:
A randomized, clinical trial with a parallel group design of 80 patients in (...) symptom improvement in hospitalized patients with COVID-19 are going to be evaluated. COVID-19 infected (...) the treatment of COVID-19
Intervention group: Hydroxychloroquine and Kaletra treatment according to
with COVID-19
Design:
Randomized, parallel group trial with blinded outcome assessment on 25 patients (...) . Randomization will be done using online website (randomization.com). The participants (patients with COVID-19(...) :
Inclusion criteria: Patients diagnosis with COVID-19; Age between 18-70 year old. Non-inclusion criteria
laboratory signs of Iranian COVID-19 patients
Design:
This study is a two arm parallel group, single blinded clinical trial in phase 2 which will be carried out on 68 hospitalized COVID-19 patients. Patients randomly divided into two groups.
Settings and conduct:
68 hospitalized COVID-19 patients in
Iranian COVID-19 patients
Design:
This study is a two arm parallel group, double blinded clinical trial in phase 2 which will be carried out on 60 hospitalized COVID-19 patients. Patients randomly divided into two groups.
Settings and conduct:
60 hospitalized COVID-19 patients in Shariati, Imam Khomeini
Study aim:
Evaluation of convalescent plasma therapy in the treatment of patients with COVID-19 disease
Design:
Criteria of selection for plasma donors
1. The persons previously infected with COVID-19(...) conduct:
1. Convalescent plasma will be received from those recovering from COVID-19 disease previously
COVID-19 in Abadan University of Medical Sciences
Design:
A parallel randomized double blind clinical (...) :
Inclusion criteria: Patients who are diagnosed as Covid-19 patients by positive PCR test or by CT Scan (...) groups:
Intervention Group: Patients with Covid-19 that will be Recipient of standard national protocol
severity and consequences of COVID-19 in inpatient cases.
Design:
Clinical trial with control group with (...)Covid-19 patients in Bu Ali Sina and Velayat hospitals in Qazvin. All patients will receive standard treatment based on recommendations of the national COVID-19 treatment guidelines. In the intervention group
Study aim:
Examination of oxycodone for the treatment of Covid-19 patients
Design:
Positive corona (...)covid19 who complain of pain and shortness of breath.
Participants/Inclusion and exclusion criteria:
Covid-19 positive patients
Patients hospitalized in the intensive care unit
Intervention groups:
After
Study aim:
Examination of the effect of protection motivation theory-based intervention on pregnant women's knowledge and self-protection regarding COVID-19.
Design:
Randomized controlled trial- pre-post (...) -protection regarding COVID-19.